Following Labcorp’s announcement that it will acquire “select assets” of BioReference Health’s laboratory testing businesses, experts shared insights on what led up to the deal. They also speculated why Labcorp will purchase some testing assets but not other testing assets. Labcorp of Burlington, NC, will pay $237.5 million. It will purchase only BioReference’s testing businesses […]
To access this post, you must purchase The Dark Report.